Results 201 to 210 of about 102,372 (372)

External Validation of a Multivariable Diagnostic Prediction Model for Acute Invasive Fungal Rhinosinusitis in Tertiary Care Settings

International Forum of Allergy &Rhinology, Volume 16, Issue 1, Page 16-22, January 2026.
ABSTRACT Background Prompt detection and intervention are crucial for improving outcomes in acute invasive fungal rhinosinusitis (AIFS). Diagnostic prediction models assist in risk‐stratification, but their accuracy requires testing through external validation.
Aviv Spillinger, Johanna Ellefson, Qiuyu Yang, Linda X. Yin, Janalee K. Stokken, Thomas Pasic, Ian J. Koszewski, Sandra Y. Lin   +7 more
wiley   +1 more source

An unusual case of acute pseudogout in the hand masquerading as cellulitis. [PDF]

Medicine (Baltimore)
Meng Y, Zhou L, Shao R, Zhag W, Pan H.
europepmc   +1 more source

A Peritonsillar Abscess Model for Ultrasound Diagnosis Using Inexpensive Materials [PDF]

, 2020
Coleman, Keel, Fortuna, Timothy, Rasheed, Mustafa   +2 more
core  

Extranodal Lymphoplasmacytic Lymphoma Responding Rapidly to Zanubrutinib: A Case Series

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Management of recurrent or atypical lymphoplasmacytic lymphoma poses a significant therapeutic challenge. Here we demonstrate a case series of three patients with atypical presentations of extranodal lymphoplasmacytic lymphoma that each show remarkable and timely responses to Zanubrutinib with a limited side effect profile.
Samuel Brown, Jillian Rusbridge, George Follows, Anna Santarsieri   +3 more
wiley   +1 more source

Susan McKenzie-Nevolas, Plaintiff, v. Deaconess Holdings LLC., Defendant. [PDF]

, 2014
Degiusti, Judge Timothy D.
core   +1 more source

Hematopoietic effects of tagraxofusp in treatment‐naive patients with blastic plasmacytoid dendritic cell neoplasm

Cancer, Volume 132, Issue 1, 1 January 2026.
Abstract Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an aggressive hematologic neoplasm that expresses CD123, is often observed in the bone marrow (BM), as well as skin, blood, and viscera. Tagraxofusp, a first‐in‐class CD123‐targeted therapy, is the only drug approved to treat BPDCN.
Marina Konopleva, Naveen Pemmaraju, Kendra L. Sweet, Anthony S. Stein, David A. Rizzieri, Eunice S. Wang, Sumithira Vasu, Todd Rosenblat, Michael Zuurman, Ira Gupta, Andrew A. Lane   +10 more
wiley   +1 more source

Development of a digital image analysis system for objective evaluation of treatment response in cellulitis. [PDF]

Sci Rep
Miyata K, Yamagami J, Takenaka Y, Onuki M, Sawayanagi T, Ishiguro N.   +5 more
europepmc   +1 more source

Periorbital and Orbital Cellulitis.

Journal of the American Medical Association (JAMA), 2020
Ioana Baiu, Elliot Melendez
semanticscholar   +1 more source

Necrotizing Fasciitis [PDF]

, 2020
Desta, Rishan, Yee, Jennifer
core  

Norplant? cellulitis

Infectious Diseases in Obstetrics and Gynecology, 1996
openaire   +2 more sources